Quantitative SPECT/CT imaging of lead-212: a phantom study

BACKGROUND: Lead-212 ((212)Pb) is a promising radionuclide for targeted therapy, as it decays to α-particle emitter bismuth-212 ((212)Bi) via β-particle emission. This extends the problematic short half-life of (212)Bi. In preparation for upcoming clinical trials with (212)Pb, the feasibility of qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Kvassheim, Monika, Revheim, Mona-Elisabeth R., Stokke, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352840/
https://www.ncbi.nlm.nih.gov/pubmed/35925521
http://dx.doi.org/10.1186/s40658-022-00481-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352840/
https://www.ncbi.nlm.nih.gov/pubmed/35925521
http://dx.doi.org/10.1186/s40658-022-00481-z

Ejemplares similares